Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Regenerative treatment for mandibular molar furcation defects using xenograft with enamel matrix derivative

Official title: Efficacy of Enamel Matrix Derivative Combined With Xenograft in the Treatment of Furcation Defects in Mandibular Molars

Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT07776756 · Data updated 2026-11-12

This randomized trial tests two regenerative approaches for mandibular molar Class II furcation defects in people with periodontitis to see which method improves healing and patient comfort.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City
Academic / other
Locations1 site (Ho Chi Minh City, Binh Phu)
StatusRecruiting
StartedJune 29, 2026
Main results expectedSeptember 29, 2027
Study endsSeptember 30, 2027
Registry record updatedAugust 20, 2026
Trial IDNCT07776756 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18+ with mandibular first/second molar Class II furcation defects (A2/B2) and suitable oral health indicators, willing to consent.

Probably not a fit

Patients with systemic conditions affecting healing or non-qualifying furcation defects may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two regenerative surgical approaches for mandibular molar Class II furcation defects in adults with periodontitis. One group receives xenograft bone plus enamel matrix derivative (EMD); the other group receives xenograft bone plus a collagen membrane. Participants will be followed for about seven months to assess clinical parameters, imaging changes, and patient-reported outcomes such as pain and satisfaction. Before and after surgery, measurements include plaque and bleeding indices, pocket depth, attachment loss, and furcation defect volume and bone density by CBCT, with GCF TWEAK levels explored. The study plans 24 teeth from eligible participants, with random assignment to the two treatments and follow-ups at 2 weeks, 1 month, 3 months, and 6 months.

Why it matters

Potential benefit: If successful, the EMD-containing approach could improve periodontal regeneration and patient-centered outcomes for challenging furcation defects.

How similar studies have gone: Prior studies suggest regenerative techniques can improve outcomes in furcation defects, but results vary by materials used; this trial evaluates two common regenerative approaches.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Full-mouth plaque score (FMPS) ≤ 20%.
* Full-mouth bleeding score (FMBS) ≤ 20%.
* Willingness to participate in the study and provide informed consent.
* Mandibular first and/or second molar with a buccal Class II furcation defect classified as subgroup A2 or B2.
* Probing pocket depth (PPD) ≥ 5 mm at the eligible furcation site.
* Keratinized gingival height ≥ 2 mm at the eligible site.
* No gingival recession extending apically beyond the buccal furcation roof; the furcation entrance must not be clinically exposed above the gingival margin.

Exclusion Criteria:

* Systemic diseases or conditions that may affect periodontal treatment outcomes, including uncontrolled diabetes mellitus, heart disease requiring anticoagulant therapy, hematologic disorders, or immunodeficiency.
* Pregnancy or breastfeeding.
* Untreated endodontic pathology involving the study tooth.
* Class III furcation involvement according to the Hamp classification.
* Untreated occlusal trauma involving the study tooth.
* Grade II tooth mobility that has not been stabilized by splinting, or Grade III tooth mobility according to the Miller classification.
* Defective restorations at the surgical site, including overhanging, bulky, or poorly adapted restorations.

Where it's running

  • Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, Binh Phu, Vietnam
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.